Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published December 12, 2006 | Published
Journal Article Open

Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy

Abstract

Selected mutations in the human α4 or β2 neuronal nicotinic acetylcholine receptor subunit genes cosegregate with a partial epilepsy syndrome known as autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). To examine possible mechanisms underlying this inherited epilepsy, we engineered two ADNFLE mutations (Chrna4S252F and Chrna4+L264) in mice. Heterozygous ADNFLE mutant mice show persistent, abnormal cortical electroencephalograms with prominent delta and theta frequencies, exhibit frequent spontaneous seizures, and show an increased sensitivity to the proconvulsant action of nicotine. Relative to WT, electrophysiological recordings from ADNFLE mouse layer II/III cortical pyramidal cells reveal a >20-fold increase in nicotine-evoked inhibitory postsynaptic currents with no effect on excitatory postsynaptic currents. i.p. injection of a subthreshold dose of picrotoxin, a use-dependent γ-aminobutyric acid receptor antagonist, reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice. Our studies suggest that the mechanism underlying ADNFLE seizures may involve inhibitory synchronization of cortical networks via activation of mutant α4-containing nicotinic acetylcholine receptors located on the presynaptic terminals and somatodendritic compartments of cortical GABAergic interneurons.

Additional Information

© 2006 by The National Academy of Sciences of the USA. Freely available online through the PNAS open access option. Communicated by Stephen F. Heinemann, The Salk Institute for Biological Studies, San Diego, CA, September 18, 2006 (received for review May 30, 2006). Published online before print December 4, 2006, 10.1073/pnas.0608215103 This work was supported by a National Institute of Neurological Disorders and Stroke Molecular and Cellular Neuroscience training grant (to A.K.), a UCLA Gonda Fellowship (to J.G.), a Stein-Oppenheimer Endowment Award (to J.B.), and National Institute of Neurological Disorders and Stroke Grants NS02808 and NS30549 (to I.M.) and NS050419 (to J.B.). I.M. and J.B. acknowledge the support of the Coelho Endowment and the Milken Family Medical Foundation, respectively. Author contributions: A.K., J.G., and J.M. contributed equally to this work; A.K., J.G., J.M., I.M., and J.B. designed research; A.K., J.G., J.M., and J.B. performed research; A.K., J.G., J.M., C.L., I.M., and J.B. contributed new reagents/analytic tools; A.K., J.G., J.M., I.M., and J.B. analyzed data; and J.B. wrote the paper. The authors declare no conflict of interest.

Attached Files

Published - KLApnas06.pdf

Files

KLApnas06.pdf
Files (1.1 MB)
Name Size Download all
md5:7430ee7d5ae35c3425bd6f2233866f1d
1.1 MB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 16, 2023